| Certification: | CE |
|---|---|
| Disinfection: | Disinfection |
| Color: | Transparent |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Trademark | Juvelook 200mg |
| Model NO. | 200mg |
| Origin | Korea |
Product Description
Juvelook is a hybrid filler that combines both the benefits of an immediate filling effect, resulting from the use of HA hyaluronic acid, and long-term stimulation of collagen production, thanks to the use of polylactic acid PDLLA (Poly D, L - lactide)
Thanks to the patented production technology, a preparation with unique properties has been created: long-term effectiveness and an increased safety profile.
Intended use:
Areas of application:
Therapy effects
The effects of therapy are visible immediately after administration. We obtain the effect of filling thanks to the presence of hyaluronic acid. After about 2 weeks, collagen production begins with the presence of PDLLA lactic acid microparticles. The effects of the therapy last for more than two years after the last treatment. The recommended number of treatments is 2 or 3 depending on the skin defect at 6-8 week intervals. After two years, it is recommended to perform 1 booster treatment.
Injection methods:
It is administered with a thin 27 g cannula in the area of the lower eyelid or with thin needles, e.g. 31 G, making injections into the lower part of the dermis to a depth of about 1.7 mm.
Strengths of JUVELOOK:
Composition
Express Logistics
){kind=link}